Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi
Department of Children's and Women's Health, University of Liverpool, Liverpool, UK.
Sex Transm Infect. 2024 Nov 18;100(8):517-523. doi: 10.1136/sextrans-2024-056130.
There are limited data on the epidemiology of sexually transmitted infections (STI) and their contribution to adverse birth outcomes (ABO) in sub-Saharan Africa (SSA). We performed a case-control study to assess the prevalence of STI and their association with ABO among women attending Queen Elizabeth Central Hospital, Blantyre, Malawi.
A composite case definition for ABO included stillborn, preterm and low birthweight infants and infants admitted to neonatal intensive care unit within 24 hours of birth. Following recruitment of an infant with an ABO, the next born healthy infant was recruited as a control. Multiplex PCR for (NG), (CT) and (TV) was performed on maternal vaginal swabs. HIV and syphilis status was determined on maternal and infant serum. For syphilis, we used combined treponemal/non-treponemal rapid point-of-care tests in parallel with rapid plasma reagin tests, PCR for and clinical parameters to diagnose and stage the infection. We compared STI positivity between cases and controls.
We included 259 cases and 251 controls. Maternal prevalence of STI was 3.1%, 2.7% and 17.1% for NG, CT and TV, respectively. Maternal prevalence of untreated syphilis was 2.0% and 6.1% for early stage and late/unknown stage, respectively; prevalence of treated syphilis was 2.7%. The HIV prevalence was 16.5%. HIV infection significantly increased the odds for ABO (OR=3.31; 95% CI 1.10 to 9.91) as did NG positivity (OR=4.30; 95% CI 1.16 to 15.99). We observed higher rates of ABO among women with untreated maternal syphilis (early: OR=7.13; 95% CI 0.87 to 58.39, late/unknown stage: OR=1.43; 95% CI 0.65 to 3.15). Maternal TV and CT infections were not associated with ABO.
STI prevalence among pregnant women in Malawi is comparable to other SSA countries. HIV, NG and untreated syphilis prevalence was higher among women with ABO compared with women with healthy infants.
在撒哈拉以南非洲(SSA),性传播感染(STI)的流行病学及其对不良出生结局(ABO)的影响的数据有限。我们进行了一项病例对照研究,以评估在马拉维伊丽莎白女王中央医院就诊的妇女中 STI 的流行率及其与 ABO 的关系。
ABO 的复合病例定义包括死产、早产和低出生体重儿以及出生后 24 小时内入住新生儿重症监护病房的婴儿。在招募一名 ABO 婴儿后,招募下一个出生的健康婴儿作为对照。对产妇阴道拭子进行 (NG)、 (CT)和 (TV)的多重 PCR 检测。在产妇和婴儿血清中确定 HIV 和梅毒状态。对于梅毒,我们使用同时进行的梅毒螺旋体/非梅毒螺旋体快速即时检测点检测以及快速血浆反应素检测、PCR 检测 以及临床参数来诊断和分期感染。我们比较了病例和对照组之间的 STI 阳性率。
我们纳入了 259 例病例和 251 例对照。NG、CT 和 TV 分别为 3.1%、2.7%和 17.1%的产妇 STI 患病率。早期和晚期/未知期未经治疗梅毒的患病率分别为 2.0%和 6.1%;治疗梅毒的患病率为 2.7%。HIV 患病率为 16.5%。HIV 感染显著增加了 ABO 的发病几率(OR=3.31;95%CI 1.10 至 9.91),NG 阳性也显著增加了 ABO 的发病几率(OR=4.30;95%CI 1.16 至 15.99)。我们观察到未经治疗的母体梅毒女性 ABO 发生率较高(早期:OR=7.13;95%CI 0.87 至 58.39,晚期/未知期:OR=1.43;95%CI 0.65 至 3.15)。母体 TV 和 CT 感染与 ABO 无关。
马拉维孕妇的 STI 流行率与其他 SSA 国家相当。与健康婴儿的母亲相比,HIV、NG 和未经治疗的梅毒在 ABO 母亲中更为常见。